NCT01437098View on ClinicalTrials.gov

Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

November 27, 2018

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

MDT-2111 CoreValve for TAVI

CoreValve Transcatheter Aortic Valve Implantation (TAVI) using the MDT-2111 system.

Trial Locations (4)

247-8533

Shonan Kamakura General Hospital, Kamakura

565-0871

Osaka University Hospital, Suita

565-8565

National Cerebral and Cardiovascular Center, Suita

350-1298

Saitama Medical University, Hidaka

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY